We will focus on the development of APIs, custom synthesis and license manufacturing to meet the requirements of the international market and our customers.

Our R&D, production and quality system is world-class, all set up according to the ICH and FDA guidelines and fully comply with cGMP.

We are now preparing series of APIs that will come off patent from 2018 to 2020. We are aiming to become one of the best API production base in the world.

By virtue of our synthetic capabilities, we are working closely with renowned MNCs to develop pharmaceutical intermediates and perform license manufacturing.